Publications

Malfatti MA, Dingley KH, Nowell-Kadlubar S, Ubick EA, Mulakken N, Nelson D, Lang NP, et al. 2006. The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans. Cancer Res 66(21):10541–10547; doi: 10.1158/0008-5472.CAN-06-1573. PMID: 17079477.

Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ. 2006. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90(2):510–518; doi: 10.1093/toxsci/kfj105.

Rogers JM. 2006. Casting a broad network: Fishing for mechanisms of retinoid teratogenicity. Toxicological highlight. Toxicol Sci 94(1):1–2; doi: 10.1093/toxsci/kfl104.

Staskal DF, Hakk H, Bauer D, Diliberto JJ, Birnbam LS. 2006. Toxicokinetics of polybrominated diphenyl ether congeners 47, 99, 100, and 153 in mice. Toxicol Sci. 94(1):28-37; doi: 10.1093/toxsci/kfl091.

Wheeler MW, Park RM, Bailer AJ. 2006. Comparing median lethal concentration values using confidence interval overlap or ratio tests. Environ Toxicol Chem 25(5):1441-4; doi: 10.1897/05-320r.1. PMID: 16704080.

Van den Berg M, Birnbaum L, Denison M, De Vito M, Farland W, Feeley M, Fiedler H, Hakansson H, Hanberg A, Haws LC, Rose M, Safe S, Schrenk D, Tohyama C, Tritscher A, Tuomisto J, Tysklind M, Walke Nr, Peterson RE. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223-241; doi: 10.1093/toxsci/kfl055.

Jackson MA, Lea I, Rashid A, Peddada SD, Dunnick JK. 2006. Genetic alterations in cancer knowledge system: Analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci 90(2):400–418; doi: 10.1093/toxsci/kfj101.

Hamernik K, Eskes C, Merrill J, Choksi N, Allen D, Truax J, et al. 2006. ICCVAM-NICEATM-ECVAM symposium on mechanisms of chemically-induced ocular injury and recovery: Current understanding and knowledge gaps. ALTEX 23 Suppl:322–324.

Mezei G, Cher D, Kelsh M, Edinboro C, Chapman P, Kavet R. 2005. Occupational magnetic field exposure, cardiovascular disease mortality, and potential confounding by smoking. Ann Epidemiol 15(8):622–629; doi: 10.1016/j.annepidem.2004.12.013.

Niple JC, Sahl JD, Kelsh MA, Kavet R. 2005. Equipment grounding affects contact current exposure: A case study of sewing machines. Ann Occup Hyg 49(8):673–682; doi: 10.1093/annhyg/mei031.

Ulrich K, Stern M, Goddard ME, Williams J, Zhu J, Dewar A, Painter HA, Jeffery PK, Gill DR, Hyde SC, Geddes DM, Takata M, Alton Show EWFW. 2005. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Lung Cell Molec Physiol 288(6):L1179-92.

Ebeler SE, Dingley KH, Ubick E, Abel S, Mitchell AE, Burns SA, et al. 2005. Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Exp Clin Res 31(1):19–27. PMID: 15921026.

Rickert DE, Dingley K, Ubick E, Dix KJ, Molina L. 2005. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation. Chem Biol Interact 155(1–2):55–61; doi: 10.1016/j.cbi.2005.04.002. PMID: 15893299.

Bailer AJ, Wheeler MW, Dankovic D, Noble R, Bena J. 2005. Incorporating uncertainty and variability in the assessment of occupational hazards. Int J Risk Assess Manage 5(2-4):344-57; doi: 10.1504/IJRAM.2005.007176.

Brown K, Dingley KH, Turteltaub KW. 2005. Accelerator mass spectrometry for biomedical research. Methods Enzymol 402:423–443; doi: 10.1016/S0076-6879(05)02014-8. PMID: 16401518.

Grasty RC, Bjork JA, Wallace KB, Lau CS, Rogers JM. 2005. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B 74(5):405–416; doi: 10.1002/bdrb.20059.

Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, Clewell HJ III, Lipscomb JC, Barton HA. 2005. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J Children’s Health 2(3–4):363–411.

Bailer AJ, Noble RB, Wheeler MW. 2005. Model uncertainty and risk estimation for experimental studies of quantal responses. Risk Anal 25(2):291-9; doi: 10.1111/j.1539-6924.2005.00590.x. PMID: 15876205.

Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85:429–446.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090.